Advertisement
Screener

EVOKE PHARMA, INC. Research and Development Expense (Excluding Acquired in Process Cost)

EVOKE PHARMA, INC. Research and Development Expense (Excluding Acquired in Process Cost)

EVOKE PHARMA, INC. reported Research and Development Expense (Excluding Acquired in Process Cost) of $5.32 thousand for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost · last filed 2025-11-13

  • EVOKE PHARMA, INC. research and development expense (excluding acquired in process cost) for the quarter ending 2025-09-30 was $5.32K, a 54.44% decline year-over-year.
  • EVOKE PHARMA, INC. research and development expense (excluding acquired in process cost) for the quarter ending 2025-06-30 was $8.41K.
  • EVOKE PHARMA, INC. research and development expense (excluding acquired in process cost) for the quarter ending 2025-03-31 was $42.78K, a 821.05% increase year-over-year.
  • EVOKE PHARMA, INC. research and development expense (excluding acquired in process cost) for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
  • EVOKE PHARMA, INC. research and development expense (excluding acquired in process cost) for fiscal 2024 was $16.32K, a 91.03% decline from fiscal 2023.
  • EVOKE PHARMA, INC. research and development expense (excluding acquired in process cost) for fiscal 2023 was $181.91K, a 39.52% decline from fiscal 2022.
  • EVOKE PHARMA, INC. research and development expense (excluding acquired in process cost) for fiscal 2022 was $300.79K, a 49.06% decline from fiscal 2021.
  • EVOKE PHARMA, INC. research and development expense (excluding acquired in process cost) for fiscal 2021 was $590.48K, a 90.99% decline from fiscal 2020.
Period endResearch and Development Expense (Excluding Acquired in Process Cost) 3 monthResearch and Development Expense (Excluding Acquired in Process Cost) 6 monthResearch and Development Expense (Excluding Acquired in Process Cost) 9 monthResearch and Development Expense (Excluding Acquired in Process Cost) 12 month
2025-09-30$5.32K
10-Q · filed 2025-11-13
$13.73K
derived: sum of 2 quarters · filed 2025-11-13
$56.52K
10-Q · filed 2025-11-13
$56.52K
derived: sum of 4 quarters · filed 2025-11-13
2025-06-30$8.41K
10-Q · filed 2025-08-14
$51.20K
10-Q · filed 2025-08-14
$51.20K
derived: sum of 3 quarters · filed 2025-08-14
$62.87K
derived: sum of 4 quarters · filed 2025-11-13
2025-03-31$42.78K
10-Q · filed 2025-05-13
$42.78K
derived: sum of 2 quarters · filed 2025-05-13
$54.46K
derived: sum of 3 quarters · filed 2025-11-13
$54.46K
derived: sum of 4 quarters · filed 2025-11-13
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13
$11.68K
derived: sum of 2 quarters · filed 2025-11-13
$11.68K
derived: sum of 3 quarters · filed 2025-11-13
$16.32K
10-K · filed 2025-03-13
2024-09-30$11.68K
10-Q · filed 2025-11-13
$11.68K
derived: sum of 2 quarters · filed 2025-11-13
$16.32K
10-Q · filed 2025-11-13
$38.88K
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30$0.00
10-Q · filed 2025-08-14
$4.64K
10-Q · filed 2025-08-14
$27.20K
derived: sum of 3 quarters · filed 2025-08-14
$27.20K
derived: sum of 4 quarters · filed 2025-08-14
2024-03-31$4.64K
10-Q · filed 2025-05-13
$27.20K
derived: sum of 2 quarters · filed 2025-05-13
$27.20K
derived: sum of 3 quarters · filed 2025-05-13
$119.56K
derived: sum of 4 quarters · filed 2025-05-13
2023-12-31$22.56K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13
$22.56K
derived: sum of 2 quarters · filed 2025-03-13
$114.92K
derived: sum of 3 quarters · filed 2025-03-13
$181.91K
10-K · filed 2025-03-13
2023-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
$92.36K
derived: sum of 2 quarters · filed 2024-11-07
$159.35K
10-Q · filed 2024-11-07
$186.55K
derived: sum of 4 quarters · filed 2024-11-07
2023-06-30$92.36K
10-Q · filed 2024-08-13
$159.35K
10-Q · filed 2024-08-13
$186.55K
derived: sum of 3 quarters · filed 2024-08-13
$226.94K
derived: sum of 4 quarters · filed 2024-08-13
2023-03-31$66.99K
10-Q · filed 2024-05-14
$94.20K
derived: sum of 2 quarters · filed 2024-05-14
$134.59K
derived: sum of 3 quarters · filed 2024-05-14
$326.06K
derived: sum of 4 quarters · filed 2024-05-14
2022-12-31$27.21K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-05-14
$67.59K
derived: sum of 2 quarters · filed 2024-05-14
$259.07K
derived: sum of 3 quarters · filed 2024-05-14
$300.79K
10-K/A · filed 2024-05-14
2022-09-30$40.39K
10-Q · filed 2023-11-09
$231.87K
derived: sum of 2 quarters · filed 2023-11-09
$273.58K
10-Q · filed 2023-11-09
$309.31K
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30$191.48K
10-Q · filed 2023-08-10
$233.19K
10-Q · filed 2023-08-10
$268.92K
derived: sum of 3 quarters · filed 2023-08-10
$350.62K
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31$41.72K
10-Q · filed 2023-05-15
$77.44K
derived: sum of 2 quarters · filed 2023-05-15
$159.14K
derived: sum of 3 quarters · filed 2023-05-15
$354.37K
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31$35.72K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-21
$117.42K
derived: sum of 2 quarters · filed 2023-03-21
$312.65K
derived: sum of 3 quarters · filed 2023-03-21
$590.48K
10-K · filed 2023-03-21
2021-09-30$81.70K
10-Q · filed 2022-11-09
$276.93K
derived: sum of 2 quarters · filed 2022-11-09
$554.75K
10-Q · filed 2022-11-09
$658.60K
derived: sum of 4 quarters · filed 2022-11-09
2021-06-30$195.23K
10-Q · filed 2022-08-10
$473.05K
10-Q · filed 2022-08-10
$576.90K
derived: sum of 3 quarters · filed 2022-08-10
$781.93K
derived: sum of 4 quarters · filed 2022-08-10
2021-03-31$277.82K
10-Q · filed 2022-05-10
$381.67K
derived: sum of 2 quarters · filed 2022-05-10
$586.70K
derived: sum of 3 quarters · filed 2022-05-10
$6.37M
derived: sum of 4 quarters · filed 2022-05-10
2020-12-31$103.85K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08
$308.88K
derived: sum of 2 quarters · filed 2022-03-08
$6.09M
derived: sum of 3 quarters · filed 2022-03-08
$6.55M
10-K · filed 2022-03-08
2020-09-30$205.03K
10-Q · filed 2021-11-10
$5.99M
derived: sum of 2 quarters · filed 2021-11-10
$6.45M
10-Q · filed 2021-11-10
$7.09M
derived: sum of 4 quarters · filed 2021-11-10
2020-06-30$5.78M
10-Q · filed 2021-08-12
$6.25M
10-Q · filed 2021-08-12
$6.89M
derived: sum of 3 quarters · filed 2021-08-12
$7.71M
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31$463.85K
10-Q · filed 2021-05-12
$1.11M
derived: sum of 2 quarters · filed 2021-05-12
$1.93M
derived: sum of 3 quarters · filed 2021-05-12
$3.13M
derived: sum of 4 quarters · filed 2021-05-12
2019-12-31$641.54K
10-K · filed 2020-03-12
$1.46M
derived: sum of 2 quarters · filed 2020-11-10
$2.67M
derived: sum of 3 quarters · filed 2020-11-10
$3.42M
10-K · filed 2021-03-11
2019-09-30$822.44K
10-Q · filed 2020-11-10
$2.03M
derived: sum of 2 quarters · filed 2020-11-10
$2.77M
10-Q · filed 2020-11-10
$3.47M
derived: sum of 4 quarters · filed 2020-11-10
2019-06-30$1.21M
10-Q · filed 2020-08-06
$1.95M
10-Q · filed 2020-08-06
$2.65M
derived: sum of 3 quarters · filed 2020-08-06
$3.27M
derived: sum of 4 quarters · filed 2020-08-06
2019-03-31$746.88K
10-Q · filed 2020-05-12
$1.44M
derived: sum of 2 quarters · filed 2020-05-12
$2.07M
derived: sum of 3 quarters · filed 2020-05-12
$3.46M
derived: sum of 4 quarters · filed 2020-05-12
2018-12-31$695.36K
10-K · filed 2020-03-12
$1.32M
derived: sum of 2 quarters · filed 2020-03-12
$2.71M
derived: sum of 3 quarters · filed 2020-03-12
$4.10M
10-K · filed 2020-03-12
2018-09-30$625.50K
10-K · filed 2020-03-12
$2.01M
derived: sum of 2 quarters · filed 2020-03-12
$3.40M
10-Q · filed 2019-11-07
$5.03M
derived: sum of 4 quarters · filed 2020-03-12
2018-06-30$1.39M
10-K · filed 2020-03-12
$2.77M
10-Q · filed 2019-08-08
$4.41M
derived: sum of 3 quarters · filed 2020-03-12
$7.12M
derived: sum of 4 quarters · filed 2020-03-12
2018-03-31$1.39M
10-K · filed 2020-03-12
$3.02M
derived: sum of 2 quarters · filed 2020-03-12
$5.73M
derived: sum of 3 quarters · filed 2020-03-12
$7.75M
derived: sum of 4 quarters · filed 2020-03-12
2017-12-31$1.63M
10-K · filed 2019-03-06
$4.35M
derived: sum of 2 quarters · filed 2019-03-06
$6.37M
derived: sum of 3 quarters · filed 2019-03-06
$7.14M
10-K · filed 2019-03-06
2017-09-30$2.72M
10-K · filed 2019-03-06
$4.74M
derived: sum of 2 quarters · filed 2019-03-06
$5.51M
10-Q · filed 2018-11-13
$7.01M
derived: sum of 4 quarters · filed 2019-03-06
2017-06-30$2.02M
10-K · filed 2019-03-06
$2.79M
10-Q · filed 2018-08-09
$4.29M
derived: sum of 3 quarters · filed 2019-03-06
$5.63M
derived: sum of 4 quarters · filed 2019-03-06
2017-03-31$770.69K
10-K · filed 2019-03-06
$2.27M
derived: sum of 2 quarters · filed 2019-03-06
$3.61M
derived: sum of 3 quarters · filed 2019-03-06
$5.71M
derived: sum of 4 quarters · filed 2019-03-06
2016-12-31$1.50M
10-K · filed 2018-03-07
$2.84M
derived: sum of 2 quarters · filed 2018-03-07
$4.94M
derived: sum of 3 quarters · filed 2018-03-07
$6.95M
10-K · filed 2018-03-07
2016-09-30$1.34M
10-K · filed 2018-03-07
$3.43M
derived: sum of 2 quarters · filed 2018-03-07
$5.45M
10-Q · filed 2017-11-14
$7.16M
derived: sum of 4 quarters · filed 2018-03-07
2016-06-30$2.10M
10-K · filed 2018-03-07
$4.11M
10-Q · filed 2017-08-14
$5.82M
derived: sum of 3 quarters · filed 2018-03-07
$7.66M
derived: sum of 4 quarters · filed 2018-03-07
2016-03-31$2.02M
10-K · filed 2018-03-07
$3.72M
derived: sum of 2 quarters · filed 2018-03-07
$5.56M
derived: sum of 3 quarters · filed 2018-03-07
$7.75M
derived: sum of 4 quarters · filed 2018-03-07
2015-12-31$1.71M
10-K · filed 2017-03-15
$3.55M
derived: sum of 2 quarters · filed 2017-03-15
$5.73M
derived: sum of 3 quarters · filed 2017-03-15
$8.15M
10-K · filed 2017-03-15
2015-09-30$1.84M
10-K · filed 2017-03-15
$4.03M
derived: sum of 2 quarters · filed 2017-03-15
$6.45M
10-Q · filed 2016-11-09
$8.62M
derived: sum of 4 quarters · filed 2017-03-15
2015-06-30$2.19M
10-K · filed 2017-03-15
$4.61M
10-Q · filed 2016-08-15
$6.78M
derived: sum of 3 quarters · filed 2017-03-15
$9.87M
derived: sum of 4 quarters · filed 2017-03-15
2015-03-31$2.42M
10-K · filed 2017-03-15
$4.60M
derived: sum of 2 quarters · filed 2017-03-15
$7.68M
derived: sum of 3 quarters · filed 2017-03-15
$10.56M
derived: sum of 4 quarters · filed 2017-03-15
2014-12-31$2.18M
10-K · filed 2016-03-10
$5.26M
derived: sum of 2 quarters · filed 2016-03-10
$8.14M
derived: sum of 3 quarters · filed 2016-03-10
$9.99M
10-K · filed 2016-03-10
2014-09-30$3.09M
10-K · filed 2016-03-10
$5.96M
derived: sum of 2 quarters · filed 2016-03-10
$7.82M
10-Q · filed 2015-11-12
$8.45M
derived: sum of 4 quarters · filed 2016-03-10
2014-06-30$2.87M
10-K · filed 2016-03-10
$4.73M
10-Q · filed 2015-08-13
$5.36M
derived: sum of 3 quarters · filed 2016-03-10
$5.44M
derived: sum of 4 quarters · filed 2016-03-10
2014-03-31$1.85M
10-K · filed 2016-03-10
$2.49M
derived: sum of 2 quarters · filed 2016-03-10
$2.57M
derived: sum of 3 quarters · filed 2016-03-10
$2.70M
derived: sum of 4 quarters · filed 2016-03-10
2013-12-31$636.42K
10-K · filed 2015-03-04
$715.15K
derived: sum of 2 quarters · filed 2015-03-04
$846.00K
derived: sum of 3 quarters · filed 2015-03-04
$956.98K
10-K · filed 2015-03-04
2013-09-30$78.73K
10-K · filed 2015-03-04
$209.58K
derived: sum of 2 quarters · filed 2015-03-04
$320.56K
derived: sum of 3 quarters · filed 2015-03-04
2013-06-30$130.85K
10-K · filed 2015-03-04
$241.83K
derived: sum of 2 quarters · filed 2015-03-04
2013-03-31$110.98K
10-K · filed 2015-03-04